20.07.2004 – 08:17

Unilabs signs a new contract for hospital laboratory services

The Unilabs laboratory in Lugano (Tessin) has
signed an agreement with two hospital establishments located in the
Lugano area. These hospitals comprise a total of 150 beds and
accommodate around 6,500 hospitalized patients and 32,000 outpatients
per year. The contract, which takes effect immediately, relates to an
estimated annual turnover of CHF 1.5 million and a minimum period of
until December 31, 2009.

The Unilabs group, listed on the Swiss Exchange since 1997, is the
leading European clinical laboratory testing group with over 1500
employees operating in 5 countries.

Edgard Zwirn, Executive Chairman, is at your disposal for any
further query (tel. +4122 909 77 77). Our press releases are also
available on the Internet at our web site www.unilabs.ch.

Contact:

Edgard Zwirn
Executive Chairman
Tel. +41/22/909'77'77
Internet: http://www.unilabs.ch

Plus de actualités: Unilabs SA

Tous Actualités Tous

08.07.2004 – 07:00
Unilabs strengthens its position in Switzerland and Spain
Geneva (ots) - Unilabs announces the signature of an agreement taking effect on August 1st 2004, under the terms of which it is buying an anatomical pathology laboratory located in a Swiss town where it already owns a laboratory specialised in the same field of activity. The annual turnover is around CHF 2 million. Unilabs has also strengthened its position in Spain by winning a tender for the management of the ...
plus
24.06.2004 – 18:12
Unilabs consolidates its position with the hospitals of the Vaud Riviera
Geneva (ots) - The hospitals of the Vaud Riviera (Montreux Hospital and Hôpital du Samaritain in Vevey) have just extended their partnership with Unilabs until 2011 by adding a new partner, the Hôpital de la Providence in Vevey. The signature of this agreement confirms the excellent collaboration started in June 2000 with the Hôpital Riviera. The contract ...
plus
09.06.2004 – 07:00
UNILABS launches a new range of early-stage diagnostic tests in Europe
Geneva (ots) - Biocheckup tests will allow early detection of signs of illness and permit evaluation of the risk factors for diseases such as diabetes, cancer or cardiovascular disease Most people are concerned by the state of their health and would like to know their predisposition to different pathologies before they become established (e.g. diabetes, cancer, ...
plus

Ces informations peuvent également vous intéresser